JLVIX
Price
$73.24
Change
-$0.62 (-0.84%)
Updated
Jun 2 closing price
Net Assets
6.35B
RWEBX
Price
$68.25
Change
+$0.27 (+0.40%)
Updated
Jun 2 closing price
Net Assets
214.46B
Interact to see
Advertisement

JLVIX vs RWEBX

Header iconJLVIX vs RWEBX Comparison
Open Charts JLVIX vs RWEBXBanner chart's image
JLVIX vs RWEBX Comparison Chart in %
View a ticker or compare two or three
VS
JLVIX vs. RWEBX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JLVIX is a Buy and RWEBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWEBX has more cash in the bank: 214B vs. JLVIX (6.36B). RWEBX pays higher dividends than JLVIX: RWEBX (0.75) vs JLVIX (0.42). JLVIX was incepted earlier than RWEBX: JLVIX (25 years) vs RWEBX (12 years). RWEBX (1.06) is less costly to investors than JLVIX (0.77). JLVIX is a more actively managed with annual turnover of: 49.00 vs. RWEBX (29.00). RWEBX has a lower initial minimum investment than JLVIX: RWEBX (250) vs JLVIX (250000). RWEBX annual gain was more profitable for investors over the last year : 7.24 vs. JLVIX (6.50). RWEBX return over 5 years is better than : 22.77 vs. JLVIX (2.46).
JLVIXRWEBXJLVIX / RWEBX
Total Expense Ratio0.761.0672%
Annual Report Gross Expense Ratio0.771.0673%
Fund Existence25 years12 years-
Gain YTD4.2195.23981%
Front LoadN/AN/A-
Min. Initial Investment250000250100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.36B214B3%
Annual Yield % from dividends0.420.7556%
Returns for 1 year6.507.2490%
Returns for 3 years20.9929.9870%
Returns for 5 years2.4622.7711%
Returns for 10 years77.9778.6299%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GKOS110.787.66
+7.43%
Glaukos Corp
NL5.910.22
+3.87%
NLI Holdings Inc.
BMO165.382.76
+1.70%
Bank of Montreal
ARDT9.270.05
+0.54%
Ardent Health Inc
TVRD3.17-0.05
-1.55%
Tvardi Therapeutics Inc